Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study
Le Treut, J., Sault, M.C., Lena, H., Souquet, P.J., Vergnenegre, A., Le Caer, H., Berard, H., Boffa, S., Monnet, I., Damotte, D., Chouaid, C.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
Mazieres, J., Cropet, C., Montané, L., Barlesi, F., Souquet, P.J., Quantin, X., Dubos-Arvis, C., Otto, J., Favier, L., Avrillon, V., Cadranel, J., Moro-Sibilot, D., Monnet, I., Westeel, V., Le Treut, J., Brain, E., Trédaniel, J., Jaffro, M., Collot, S., Ferretti, G.R., Tiffon, C., Mahier-Ait Oukhatar, C., Blay, J.Y.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial
Quoix, E., Audigier Valette, C., Lavolé, A., Molinier, O., Westeel, V., Barlesi, F., Le Treut, J., Pichon, E., Dauba, J., Otto, J., Dumont, P., Moreau, L., Madelaine, J., Margery, J., Debieuvre, D., Renault, P.A., Langlais, A., Morin, F., Moro-Sibilot, D., Souquet, P.-J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Vemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial
Mazières, J., Montané, L., Barlesi, F., Quantin, X., Trédaniel, J., Le Treut, J., Avrillon, V., Lavolé, A., Westeel, V., Orsini Piocelle, F., Pichon, E., Thiberville, L., Borel, C., Renault, P.A., Jaffro, M., Collot, S., Ferretti, G., Legrand, F., Mahier Ait Oukhatar, C., Blay, J.Y.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study
Payen, T., Trédaniel, J., Moreau, L., Larivé, S., Le Treut, J., Nocent, C., Hominal, S., Grangeon, V., Bizec, J.-L., Molinier, O., Debieuvre, D.
Published in Respiratory medicine and research (01.11.2021)
Published in Respiratory medicine and research (01.11.2021)
Get full text
Journal Article
1249P Health-related quality of life (HRQoL) at diagnosis for unresectable stage III NSCLC: Results from the French nationwide prospective study OBSTINATE (GFPC 06-2019)
Ricordel, C., Anota, A., Monnet, I., Martinez, S., Simmoneau, Y., Falchero, L., Guisier, F., De Chabot, G., Abdiche, S., Quere, G., Hominal, S., Demaegdt, A., Le Treut, J., Bayle, S., Pinsolle, J., Chatellier, T., Kaluzinski, L., Vieillot, S., Chouaid, C., Greillier, L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
P1.01B.05 Real-World Data on 3-Year Survival in Non-Small Cell Lung Cancer (NSCLC): Results from 3 French Nationwide Cohorts from 2000 To 2020
Debieuvre, D., Delclaux, B., De Chabot, G., Al Freijat, F., Le Treut, J., Tavernier, J.-Y., Leleu, O., Kuntz, P., Loutski, S., Fouet, K., Dot, J.M., Popa, M., Belle, A., Vincent, C., Julien, S., Perrin, C., Banciu, N., Virally, J., Lamotte, F., Morel, H.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
937P Incidence and outcomes of EGFR mutated non-small cell lung cancer treated with surgery: EXERPOS GFPC study
Auliac, J.B., Simmoneau, Y., Thomas, P.A., Guisier, F., Bylicki, O., Curcio, H., Swalduz, A., Wislez, M., Geier, M., J. Le Treut, Decroisette, C., Falchero, L., Tricard, J., Moreau, D., Huchot, E., De Chabot, G., Leroy, K., Mansuet, A. Lupo, Chouaid, C., Greillier, L.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1202P ALK-2016-CPHG: French cohort of advanced non-small cell lung cancer (aNSCLC) with ALK (ALK+) or ROS1 (ROS1+) gene rearrangement treated by crizotinib
Debieuvre, D., Locher, C., Morel, H., Baranzelli, A., Falchero, L., Romand, P., Roa, M., Delclaux, B., Bizieux-Thaminy, A., Bugnet, A-S., Grelier, J., Dayen, C., Decroisette, C., Martinez, S., Goutorbe, F., Moreau, L., Cloarec, N., Molinier, O., Le Treut, J., Duval, Y.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
EP1.01-05 EGFR-2013-CPHG, a Real-World Study of EGFR Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with Erlotinib
Debieuvre, D., Tredaniel, J., Moreau, L., Larivé, S., Le Treut, J., Nocent, C., Hominal, S., Grangeon, V., Bizec, J., Molinier, O., Payen, T.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
215TiP A phase II study of durvalumab (MEDI 4736) maintenance in frail limited disease small cell lung cancer patients after thoracic chemo-radiotherapy (CRT): DURVALUNG trial
Gobbini, E., Filleron, T., Thureau, S., Falchero, L., Le Treut, J., Bonetto, R., Bernardi, M., Benyoub, S., Stoffaes, L., Simon, C., Lamrani-Ghaouti, A., Doyen, J.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
LBA53 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients (pts) treated with PD1/L1 immune checkpoint inhibitors (ICIs): A first analysis of the PIONeeR study
Barlesi, F., Greillier, L., Monville, F., Foa, C., J. le Treut, Audigier-Valette, C., Vély, F., Garcia, S., Sabatier, F., Ciccolini, J., Fabre, M., Le Ray, M., Resseguier, N., Outters, P., Roumieux, M., Mazieres, J., Pérol, M., Vivier, E., Auquier, P., Fieschi, J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study
Fournel, Pierre, Robinet, Gilles, Thomas, Pascal, Souquet, Pierre-Jean, Léna, Hervé, Vergnenégre, Alain, Delhoume, Jean-Yves, Le Treut, Jacques, Silvani, Jules-Antoine, Dansin, Eric, Bozonnat, Marie-Cécile, Daurés, Jean-Pierre, Mornex, Françoise, Pérol, Maurice
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
P1.04-30 Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance
Barlesi, F., Pérol, D., Mazieres, J., Perol, M., Varoqueaux, N., Monville, F., Audigier-Valette, C., Barre, P., Domergue, F., Falchero, L., Foa, C., Frikha, A., Hominal, S., Le Treut, J., Zahi, S., Roumieux, M., Olive, D., Vivier, E.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach
Grimaud, Fabien, Penaranda, Guillaume, Stavris, Chloé, Retornaz, Frédérique, Brunel, Véronique, Cailleres, Sylvie, Pegliasco, Hervé, Le Treut, Jacques, Grisoni, Vincent, Coquet, Emilie, Chiche, Laurent, Rognon, Amélie
Published in Therapeutics and clinical risk management (2021)
Published in Therapeutics and clinical risk management (2021)
Get full text
Journal Article
P2.15-29 Eligibility for Anti-Angiogenic Treatments in Patients with Squamous Non-Small Cell Lung Cancer (SQ-NSCLC): EPISQUAMAB Study (GFPC 2015-01)
Vergnenegre, A., Basse, V., Le Garff, G., Bylicki, O., Dubos-Arvis, C., Comet, B., Marcq, M., Le Treut, J., Auliac, J.B., Madroszyk, A., Fraboulet, G., Crequit, J., Thomas, P., Paleiron, N., Monnet, I.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
P1.04-31 Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study
Bylicki, O., Guisier, F., Monnet, I., Doubre, H., Gervais, R., Janicot, H., Pérol, M., Fournel, P., Le Treut, J., Lamy, R., Vieillot, S., Le Caer, H., Auliac, J., Chouaid, C.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
1488PVemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial
Mazières, J, Montané, L, Barlesi, F, Quantin, X, Trédaniel, J, Le Treut, J, Avrillon, V, Lavolé, A, Westeel, V, Orsini Piocelle, F, Pichon, E, Thiberville, L, Borel, C, Renault, P A, Jaffro, M, Collot, S, Ferretti, G, Legrand, F, Mahier Ait Oukhatar, C, Blay, J Y
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
LBA56Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial
Quoix, E, Audigier Valette, C, Lavolé, A, Molinier, O, Westeel, V, Barlesi, F, Le Treut, J, Pichon, E, Dauba, J, Otto, J, Dumont, P, Moreau, L, Madelaine, J, Margery, J, Debieuvre, D, Renault, P A, Langlais, A, Morin, F, Moro-Sibilot, D, Souquet, P-J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
OA15.02 Carboplatin-Etoposide Versus Topotecan as Second-Line Treatment for Sensitive Relapsed Small-Cell Lung Cancer: Phase 3 Trial
Baize, N., Monnet, I., Greillier, L., Geier, M., Lena, H., Janicot, H., Vergnenegre, A., Crequit, J., Lamy, R., Auliac, J.B., Le Treut, J., Le Caer, H., Gervais, R., Dansin, E., Madroszyk, A., Renault, P., Legarff, G., Schott, R., Saulnier, P., Chouaid, C.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article